Key facts
- This page summarizes John F. Carey's Form 4 filing for TransMedics Group, Inc. (TMDX).
- 9 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 Feb 2023, 16:12.
John F. Carey - 01 Feb 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)
- Reporting relationship
- VP of Operations
- Issuer ticker
- TMDX
- Reported as of
- 01 Feb 2023
- Net transaction value
- -$65,222
- SEC form
- 4
- Accepted by SEC
- 03 Feb 2023, 16:12:57 UTC
- Prior SEC filing
- 18 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Stephen Gordon, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John F. Carey filed Form 4 for TransMedics Group, Inc. (TMDX) on 03 Feb 2023.
Change
- Previous filing in this sequence was filed on 18 Jan 2023.
- Current net transaction value: -$65,222.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TMDX
transaction
Common Stock
Options Exercise
- Transaction value
- $21,999
- Shares
- +1,363
- Change %
- +9.7%
- Price
- $16.14*
- Shares after
- 15,483
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
TMDX
transaction
Common Stock
Options Exercise
- Transaction value
- $1,808
- Shares
- +47
- Change %
- +0.3%
- Price
- $38.46
- Shares after
- 15,530
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
TMDX
transaction
Common Stock
Sale
- Transaction value
- $36,084
- Shares
- -582
- Change %
- -3.7%
- Price
- $62.00
- Shares after
- 14,948
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F1, F2
TMDX
transaction
Common Stock
Sale
- Transaction value
- $23,695
- Shares
- -379
- Change %
- -2.5%
- Price
- $62.52
- Shares after
- 14,569
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F1, F3
TMDX
transaction
Common Stock
Sale
- Transaction value
- $6,148
- Shares
- -96
- Change %
- -0.66%
- Price
- $64.04
- Shares after
- 14,473
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F1, F4
TMDX
transaction
Common Stock
Sale
- Transaction value
- $9,018
- Shares
- -139
- Change %
- -0.96%
- Price
- $64.88
- Shares after
- 14,334
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F1, F5
TMDX
transaction
Common Stock
Sale
- Transaction value
- $14,083
- Shares
- -214
- Change %
- -1.5%
- Price
- $65.81
- Shares after
- 14,120
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F1, F6
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TMDX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -1,363
- Change %
- -22%
- Price
- $0.000000
- Shares after
- 4,887
- Date
- 01 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,363
- Exercise price
- $16.14
- Footnotes
- F1, F7
TMDX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -47
- Change %
- -0.35%
- Price
- $0.000000
- Shares after
- 13,543
- Date
- 01 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 47
- Exercise price
- $38.46
- Footnotes
- F1, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
John F. Carey is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 8 footnotes
Footnote F1
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
Footnote F2
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.23 to $62.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F3
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.23 to $63.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F4
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.43 to $64.41, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F5
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.45 to $65.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F6
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.45 to $65.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F7
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
Footnote F8
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.
SEC remarks
The reporting person is no longer subject to Section 16 in connection with his transactions in securities of the Company and therefore will no longer report any such transactions on Form 4 or Form 5.